Farrell Michael J. 4

What Happened

• Michael J. Farrell, a director of Zimmer Biomet Holdings (ZBH), was granted two awards on 2026-05-22: 875.350 phantom stock units and 1,517.274 restricted stock units (total 2,392.624 units). Both awards have an acquisition/strike price of $0.00 (they are grants, not purchases) and are reported as derivative securities.

Key Details

• Transaction date: 2026-05-22; Form 4 filed: 2026-05-27 (filed after the typical two-business-day deadline for Form 4; the filing appears late).
• Awards and amounts: 875.350 phantom stock units (F1) and 1,517.274 restricted stock units (RSUs) (F5). Total = 2,392.624 units.
• Price: $0.00 per unit (these are awards/grants, not cash purchases).
• Conversion: Derivative conversion/exercise is 1-for-1 into common shares (F2).
• Settlement/deferral: Phantom units are to be settled in shares within 60 days after the director stops service (F3). The RSUs are immediately 100% vested but subject to mandatory deferral until the later of the reporting person’s termination as a director or three years after the grant date (F5). Some RSUs granted in prior years remain subject to different deferral schedules (F6).
• Dividend credit: The phantom units include 53.557 units credited under the plan’s dividend reinvestment provision (F4).
• Shares owned after transaction: Not specified in the filing.

Context

• These are awards (not open-market purchases or sales). Phantom stock units and RSUs give the holder economic exposure to company stock but may be settled and/or deferred per plan rules; they do not provide immediate cash proceeds or indicate a sale. The filing shows no immediate sale or exercise-for-cash.